Rx COPAY INCREASES MAY BACKFIRE ON COST CUTTERS
Employers hoping to reduce the rising cost of employeehealth coverage should think twice before raising prescriptiondrug copays for workers, researchers at Carnegie MellonUniversity found in a new study of health care expenses.
?What most employers don?t consider is that increasedcopays on drugs may lead to an increase in other types ofhealth care,? explained a spokesman for the researchers.
The authors of the study, published recently in Forum forHealth Economics and Policy, concluded that when prescriptioncopays rise employees react by buying fewer drugs, savingmoney for the employer. The higher copay requirements,however, also encourage workers to rely on health care ?substitutions.?This result leads to increased physician or emergencyroom visits, which are more costly in the long run.
Articles in this issue
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Advise Patients About Self-Care Measures to Treat Mild to Moderate GI Issues
September 18th 2025
- Evaluation of Pharmacist-Driven Penicillin Allergy Reconciliation
September 17th 2025
- Pharmacists Can Apply Their Expertise to the Medical Psilocybin Act
September 16th 2025
- From Curiosity to Clinical Impact: Shremo Msdi’s Path in Pharmacy Research
September 15th 2025